Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Clinical
    • Critical Care
    • Procedures
    • COVID-19
  • Practice Management
    • Quality
    • Public Policy
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Learning Portal
    • The Hospital Leader Blog
    • From SHM
    • SIG Spotlight
    • Chapter Spotlight

An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Clinical
    • Critical Care
    • Procedures
    • COVID-19
  • Practice Management
    • Quality
    • Public Policy
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Learning Portal
    • The Hospital Leader Blog
    • From SHM
    • SIG Spotlight
    • Chapter Spotlight

Endocrinology

  • 1
    News

    More from DAPA-HF: Dapagliflozin quickly reduces heart failure events

    February 22, 2021

    Secondary analysis of DAPA-HF showed dapagliflozin significantly cut CV deaths or worsening heart failure within 28 days on treatment.

  • 1
    News

    Quick byte: Curing diabetes

    February 19, 2021

    “If it works in people as well as it does in animals, it’s possible that people will not be diabetic.”

  • 1
    News

    DAPT increases bleeding without decreasing mortality in patients with coronary disease and diabetes

    February 2, 2021

    In patients who have diabetes with known coronary disease but without prior MI or stroke, what is the effect of dual-antiplatelet therapy (DAPT) with aspirin and ticagrelor on cardiovascular outcomes and bleeding events?

  • News

    Protecting patients with diabetes from impact of COVID-19

    January 28, 2021

    Comprehensive report summarizes best practices to protect those with diabetes from impact of pandemic, from prior 2-day Diabetes Technology Society meeting.

  • News

    Further warning on SGLT2 inhibitor use and DKA risk in COVID-19

    January 19, 2021

    Five new cases of euglycemic diabetic ketoacidosis seen in T2D patients with acute COVID-19 illness.

  • News

    Biomarker HF risk score envisioned as SGLT2 inhibitor lodestar in diabetes

    January 19, 2021

    Together, four “easily measured” biomarkers predicted 5-year heart failure risk in patients with diabetes or prediabetes, potentially identifying best candidates for SGLT2 inhibitor therapy, some say.

  • 1
    News

    Natural history of adrenal incidentalomas with and without mild autonomous cortisol excess

    December 10, 2020

    Is there significant change in the tumor size or hormonal function of benign nonfunctioning adrenal tumors (NFATs) or adenomas causing mild autonomous cortisol excess (MACE) over time?

  • News

    Prioritize COVID-19 vaccination in both types of diabetes, say docs

    December 9, 2020

    The study is the first to prospectively evaluate COVID-19 severity factors and death in people with type 1 and type 2 diabetes separately.

  • News

    Diabetic retinopathy may predict greater risk of COVID-19 severity

    December 3, 2020

    “Our study reports the first description of diabetic retinopathy as a potential risk factor for poor COVID-19 outcomes,” said the authors of a new study.

  • News

    Blood glucose on admission predicts COVID-19 severity in all

    November 30, 2020

    Those with abnormally high glucose levels were more than twice as likely to die from the virus than were those with normal readings.

Previous1 … 3 4 5 6 7 … 17Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Style Guide for Authors
  • Subscribe
  • Advertise
  • Copyright © 2000-2022 by the Society of Hospital Medicine and related companies. All rights reserved. ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement